Sinopharm Group Co. Ltd.
1099
Rank in Stocks
#2952
Sinopharm Group Co. Ltd. is a prominent player in the People's Republic of... Sinopharm Group Co. Ltd. is a prominent player in the People's Republic of China's healthcare market, specializing in the wholesale and retail of pharmaceuticals, medical devices, and related health products. The company's business activities are organized across four main divisions. Its Pharmaceutical Distribution segment supplies pharmaceutical goods to a wide range of clients, including hospitals, fellow distributors, retail pharmacies, and clinics. This division additionally offers extensive distribution, logistics, and value-added support to both domestic and international manufacturers and suppliers in the pharmaceutical and healthcare sectors. The Medical Devices segment is solely focused on the distribution of various medical equipment. Through its Retail Pharmacy division, Sinopharm manages and franchises a vast chain of drug stores, with an impressive 10,259 locations as of December 31, 2021. The "Other Business" segment is involved in the manufacturing and sale of pharmaceutical products, chemical reagents, and laboratory supplies. Beyond these core areas, the company also engages in property rental and management. It further distributes specialized items such as medical instruments, traditional Chinese herbal medicines, antibiotics, and biological products. Sinopharm provides a comprehensive array of services, including IT development, medicine and health consultations, investment services, import/export facilitation for goods and technology, various business and market information consulting, and the organization of conventions and exhibitions. Moreover, it oversees medical project investments, offers related consulting, and provides technological training. Notably, Sinopharm Group has established a strategic alliance with I-Mab to enhance its commercial capabilities and accelerate its market entry strategies. Founded in Shanghai, China, in 2003, Sinopharm Group Co. Ltd. operates as a subsidiary of Sinopharm Industrial Investment Co., Ltd.
Share Price
$2.00
Market Cap
$6.26B
Change (1 day)
1.95%
Change (1 year)
-16.78%
Country
CN
Trade Sinopharm Group Co. Ltd. (1099)
Category
Healthcare
Revenue for Sinopharm Group Co. Ltd. (1099)
Revenue in Jun 2026 TTM: $82.31B
According to Sinopharm Group Co. Ltd. latest financial reports the company's current revenue (TTM) is $82.31B. In 2023 the company made a revenue of $84.28B an increase over the revenue in the year 2022 that was $80.05B. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Sinopharm Group Co. Ltd. from 2006 to 2026
Revenue at the end of each year
| Year | Revenue | Change |
|---|---|---|
| 2026 (TTM) | $82.31B | 2.79% |
| 2024 | $80.08B | -4.98% |
| 2023 | $84.28B | 5.29% |
| 2022 | $80.05B | -2.36% |
| 2021 | $81.98B | 17.34% |
| 2020 | $69.87B | 14.40% |
| 2019 | $61.07B | 21.94% |
| 2018 | $50.09B | 17.63% |
| 2017 | $42.58B | 14.53% |
| 2016 | $37.18B | 5.57% |
| 2015 | $35.21B | 8.99% |
| 2014 | $32.31B | 17.45% |
| 2013 | $27.51B | 26.33% |
| 2012 | $21.78B | 34.29% |
| 2011 | $16.22B | 54.59% |
| 2010 | $10.49B | 52.22% |
| 2009 | $6.89B | 23.13% |
| 2008 | $5.60B | 31.35% |
| 2007 | $4.26B | 40.12% |
| 2006 | $3.04B | 0.00% |
Revenue for similar companies or competitors
| Company | Revenue | Revenue Difference | Country |
|---|---|---|---|
| $410.98B | 399.29% |
US
|
|
| - | - |
US
|
|
| $254.25B | 208.88% |
US
|
|
| - | - |
US
|
|
| $7.64B | -90.72% |
AU
|
